<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/76119A17-D4F8-4258-80F0-C8B307FFFA52"><gtr:id>76119A17-D4F8-4258-80F0-C8B307FFFA52</gtr:id><gtr:name>Radboud University Nijmegen</gtr:name><gtr:address><gtr:line1>Radboud University Nijmegen</gtr:line1><gtr:line2>PO Box 9102</gtr:line2><gtr:line4>Nijmegen</gtr:line4><gtr:postCode>6500 HC</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB"><gtr:id>FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB</gtr:id><gtr:name>University College Dublin</gtr:name><gtr:address><gtr:line1>Belfield</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/93B13D3A-863C-46E8-A4C7-1EE4759A7E9B"><gtr:id>93B13D3A-863C-46E8-A4C7-1EE4759A7E9B</gtr:id><gtr:name>Cleveland Clinic</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/FC59975E-26E8-4A62-ABD8-A570DC6ABF06"><gtr:id>FC59975E-26E8-4A62-ABD8-A570DC6ABF06</gtr:id><gtr:name>Keele University</gtr:name><gtr:department>Inst for Science and Tech in Medicine</gtr:department><gtr:address><gtr:line1>Keele</gtr:line1><gtr:line4>Newcastle</gtr:line4><gtr:line5>Staffordshire</gtr:line5><gtr:postCode>ST5 5BG</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC59975E-26E8-4A62-ABD8-A570DC6ABF06"><gtr:id>FC59975E-26E8-4A62-ABD8-A570DC6ABF06</gtr:id><gtr:name>Keele University</gtr:name><gtr:address><gtr:line1>Keele</gtr:line1><gtr:line4>Newcastle</gtr:line4><gtr:line5>Staffordshire</gtr:line5><gtr:postCode>ST5 5BG</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/76119A17-D4F8-4258-80F0-C8B307FFFA52"><gtr:id>76119A17-D4F8-4258-80F0-C8B307FFFA52</gtr:id><gtr:name>Radboud University Nijmegen</gtr:name><gtr:address><gtr:line1>Radboud University Nijmegen</gtr:line1><gtr:line2>PO Box 9102</gtr:line2><gtr:line4>Nijmegen</gtr:line4><gtr:postCode>6500 HC</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB"><gtr:id>FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB</gtr:id><gtr:name>University College Dublin</gtr:name><gtr:address><gtr:line1>Belfield</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/93B13D3A-863C-46E8-A4C7-1EE4759A7E9B"><gtr:id>93B13D3A-863C-46E8-A4C7-1EE4759A7E9B</gtr:id><gtr:name>Cleveland Clinic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/52C910B7-3262-497A-BA05-17D4C849D141"><gtr:id>52C910B7-3262-497A-BA05-17D4C849D141</gtr:id><gtr:firstName>Angela</gtr:firstName><gtr:surname>Patterson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/990AA4F3-7D1A-4962-9F58-493BD03C858A"><gtr:id>990AA4F3-7D1A-4962-9F58-493BD03C858A</gtr:id><gtr:firstName>Jim</gtr:firstName><gtr:surname>Middleton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0401634"><gtr:id>195D8EFB-5DB3-4D4D-A109-A76EB67072E2</gtr:id><gtr:title>Syndecan-3 in leukocyte extravasation and arthritis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401634</gtr:grantReference><gtr:abstractText>Rheumatoid arthritis in a common, debilitating and painful disease affecting about 1% of the population and can result in increased mortality. Migration of leukocytes (white cells) from the blood into rheumatoid joints is enhanced by molecules called chemokines. Carbohydrates on the endothelial cells that line blood vessels bind chemokines and present chemokines to leukocytes in the blood. We have found that a particular carbohydrate-bearing molecule, syndecan-3, on the endothelial cells in rheumatoid arthritis binds the chemokine CXCL8. The project aim is to elucidate the importance of syndecan-3-chemokine interactions in rheumatoid arthritis. This will be carried out by studying mice that do not possess syndecan-3. The migration of leukocytes into tissues will be studied in syndecan-3 deleted mice to examine if this differs compared to normal animals. In addition, it will be determined if the severity of arthritis in these mice is altered compared to normal. Therefore this work could lead to greater understanding of disease mechanisms in rheumatoid arthritis and targeting syndecan-3 could ultimately be used as a new type of treatment.
 The research work will be presented at our annual hospital open day. This day is advertised widely and the general public and scientific professionals visit the laboratories and hear about the medical research being carried out in the hospital and medical school. In addition, we have groups of school pupils come and view the work we perform in order to foster an interest in science. When grants are awarded to our research centre an article is written for the local newspaper (The Shropshire Star) describing the research in lay terms. Furthermore, at a later date the results of the research would be published in popular journals and local or national newspapers as appropriate. All these lay communication activities are part of an existing programme and will not incur extra costs. 
 The work would also be presented to the scientific community and health professionals at congresses in terms of oral and poster presentations, and in written form in published peer-reviewed journals.</gtr:abstractText><gtr:technicalSummary>Chemokines enhance the migration of blood leukocytes into the synovium in rheumatoid arthritis (RA). There is evidence that endothelial heparan sulphate proteoglycan (HSPG) is involved in transcytosing and presenting chemokines to blood leukocytes, resulting in leukocyte extravasation into the tissue. We have evidence that a particular endothelial HSPG, syndecan-3, binds the chemokine CXCL8 (IL-8) in the rheumatoid synovium. The overall aim of the project is to examine the functional role of syndecan-3 in leukocyte extravasation and the initiation and progression of arthritis. Using syndecan-3 gene deleted mice it will be investigated if leukocyte migration into the skin in response to chemokines is altered compared to wild-type animals. It will be elucidated if leukocyte firm adhesion, which is triggered by chemokines, is altered in syndecan-3 null mice using intravital microscopy. Furthermore, an antigen-induced arthritis model will be performed in these knock-out mice to determine if leukocyte infiltration into the joint and disease severity are influenced and if the effects are chemokine-related. The purpose of the study is to test the hypothesis that endothelial syndecan-3-chemokine interactions are important in regulating leukocyte extravasation and the pathophysiology of arthritis. The successful outcome of the study will further the understanding of chronic inflammatory disease and identify syndecan-3 as a potential therapeutic target in RA, leading ultimately to potential benefits in terms of improving human health.</gtr:technicalSummary><gtr:fund><gtr:end>2010-12-04</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-12-05</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>185009</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cleveland Clinic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>syndecan-3 knock out mice</gtr:description><gtr:id>C1449DF0-CF2A-494A-A037-04E173E9155B</gtr:id><gtr:impact>publication of research paper in Arthritis Research and Therapy</gtr:impact><gtr:outcomeId>544e60c2d00139.85943778-1</gtr:outcomeId><gtr:partnerContribution>They provided syndecan-3 knock-out mice</gtr:partnerContribution><gtr:piContribution>Understanding the function of syndecan-3 in inflammation</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Radboud University Nijmegen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Use of phage display antibodies to detect specific heparan sulphte structures on syndecan</gtr:description><gtr:id>447067BC-94CA-449C-9CBB-4F3CD3703BD7</gtr:id><gtr:impact>One publication showing the presence of these structures on endothelial cells in inflamed tissues</gtr:impact><gtr:outcomeId>10EE93DC8A3-1</gtr:outcomeId><gtr:partnerContribution>They generated phage display antibodies to specific glycosaminoglycan structures on syndecan</gtr:partnerContribution><gtr:piContribution>We have managed to demonstrate specific structures on syndecan-3 that may be involved in the presentation of chemokines to leukocytes. This then results in leukocyte migration into inflamed tissues.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Syndecan-3 expression</gtr:description><gtr:id>E8F00ADC-8F98-4917-906F-2B44406F5BD6</gtr:id><gtr:impact>Publication</gtr:impact><gtr:outcomeId>bCzD1mBAoR1-1</gtr:outcomeId><gtr:partnerContribution>providing clinically defined samples</gtr:partnerContribution><gtr:piContribution>Defining syndecan-3 expression in arthritis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Research Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>374F5432-4783-4A9A-AA35-71189D802067</gtr:id><gtr:impact>50 local members of the public and profesional scienstists attended talks and poster sessions, and were shown around the labs.

Local fund raisers donated funds for our research.</gtr:impact><gtr:outcomeId>CbfVo93KoBj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2019D5A6-F07C-40AD-84B2-81E464A180B9</gtr:id><gtr:impact>Talk about or research, practical demonstrations at a hospital open day

Increase in public awarness</gtr:impact><gtr:outcomeId>bqYHrJw95mb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0EC9BFA8-3A17-4E1F-BF66-6EA4E23D5805</gtr:id><gtr:impact>Talk about or research, practical demonstrations at a hospital open day

Increase in public awarness</gtr:impact><gtr:outcomeId>pucjL1CCrL7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DE0CC5A4-4DA3-48B6-9BBA-21F569141354</gtr:id><gtr:impact>Talk about or research, practical demonstrations at a hospital open day


Increase in public awarness</gtr:impact><gtr:outcomeId>hLSdCaUDFjU</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open Day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2899CB7A-EF5D-4B79-BAB5-CF872DB5ABE5</gtr:id><gtr:impact>Talk about or research, practical demonstrations at a hospital open day


Increase in public awarness</gtr:impact><gtr:outcomeId>kLAPUKAZRY3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Oswestry</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3486CED3-6EE0-4A6D-8A69-B303056E9202</gtr:id><gtr:impact>They heard about the research and performed some hands-on experiments

They generated further interest in science and pathology</gtr:impact><gtr:outcomeId>FF4D2CD911C</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Charity talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9CC5C61B-C6A2-4DF7-AFEA-9A5A45B49725</gtr:id><gtr:impact>Talk about our research to a patient and fund raising group

Interest in funding the research</gtr:impact><gtr:outcomeId>iJt5JW7GAx7</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>91520465-DB37-4D4F-9B44-0CDC9AA629EB</gtr:id><gtr:impact>Talk about or research, practical demonstrations at a hospital open day



Increase in public awarness</gtr:impact><gtr:outcomeId>oE3qULBnbaW</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>52341E4B-1C42-4AEA-9423-96A905B3F6A4</gtr:id><gtr:impact>A day when members of the public visit our labs and see the research

The public had an increased understanding of our research</gtr:impact><gtr:outcomeId>890EDE81DA0</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>94928</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DTC</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5E2E8364-2A18-4733-8ED9-9DE2F11C17B4</gtr:id><gtr:outcomeId>544e69472b8113.12375966</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>113000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Institute of Orthopaedics at Oswestry, Project grant</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Institute of Orthopaedics</gtr:fundingOrg><gtr:id>3BE2ECBB-974E-41A3-87DE-6104F56E5A85</gtr:id><gtr:outcomeId>LUGy155DWW40</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>88000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC/CASE</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>80BF198F-1EAC-4769-8D5D-38E4F0035414</gtr:id><gtr:outcomeId>544e68a2995de7.06527798</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>115000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK Project Grant</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>D38189DE-3389-4B38-9DEF-040DD8937531</gtr:id><gtr:outcomeId>mG6c9r4E1DC0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>51000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/ACORN studentship</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>28A02675-20D2-4BE8-8071-F6781274010A</gtr:id><gtr:outcomeId>Su3r6qS183D0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>a method has been devised to extract synovial endothelail cells. These cells can be used for collaborators and ourselves to examine mechanisms of inflammation in vitro.</gtr:description><gtr:id>7BBC89E3-DEFD-411D-BCCE-733A8668A14D</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>pVJCC37h7pb</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>synovial endothelial cells</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A chemokine administration protocol has been signficantly improved in mouse skin to assess the effect of syndecan-3 gene deletion on inflammation.</gtr:description><gtr:id>EBA8C036-0965-4C66-A270-693CD326A7C9</gtr:id><gtr:impact>It allows us to assess the role of syndecan-3 in inflammation.</gtr:impact><gtr:outcomeId>1741B32203E</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>An improved model of inflammation in skin</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Samples rheumatoid synovium and cartilage have been collected from over 200 patients making a significant tissue bank.</gtr:description><gtr:id>FB827AF1-93C4-4A7F-8155-F17F83468193</gtr:id><gtr:impact>about 20 papers have published using this material.</gtr:impact><gtr:outcomeId>RzYsYEwX9xG</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>synovial samples</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CB1727FB-62BE-410C-A110-5323FA1A7F28</gtr:id><gtr:title>Defining the fine structure of heparan sulfate on endothelial cells in rheumatoid synovium.</gtr:title><gtr:parentPublicationTitle>Annals of the Rheumatic Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64d7d53999bcd852c710b3091d573a0b"><gtr:id>64d7d53999bcd852c710b3091d573a0b</gtr:id><gtr:otherNames>Kehoe O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>TAn7uRgcCTx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A406720D-AEDC-4BC2-B833-ADC63FCE15C2</gtr:id><gtr:title>The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a67232ea00c040942111c5092c7684d7"><gtr:id>a67232ea00c040942111c5092c7684d7</gtr:id><gtr:otherNames>Pruenster M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>fm9STBGBZkX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>136AA32F-A951-4B25-99A6-DBCC0DD1C4FC</gtr:id><gtr:title>A chemokine self-presentation mechanism involving formation of endothelial surface microstructures.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d407031a8d8242ed7bb14e155a570abd"><gtr:id>d407031a8d8242ed7bb14e155a570abd</gtr:id><gtr:otherNames>Whittall C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>UaJhbisJQqi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32096D3A-95A4-4BA0-B5DA-9983814A5AEB</gtr:id><gtr:title>Duffy antigen receptor for chemokines and CXCL5 are essential for the recruitment of neutrophils in a multicellular model of rheumatoid arthritis synovium.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/189e6bc991e4a601e3505b421420837d"><gtr:id>189e6bc991e4a601e3505b421420837d</gtr:id><gtr:otherNames>Smith E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>hZ4NiJdysuC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FE2198E-35EE-4C41-B581-77AB85D78079</gtr:id><gtr:title>Syndecan-3 is selectively pro-inflammatory in the joint and contributes to antigen-induced arthritis in mice.</gtr:title><gtr:parentPublicationTitle>Arthritis research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64d7d53999bcd852c710b3091d573a0b"><gtr:id>64d7d53999bcd852c710b3091d573a0b</gtr:id><gtr:otherNames>Kehoe O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1478-6354</gtr:issn><gtr:outcomeId>544e5d9976c6c1.73753186</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BED6618-38A3-45B2-985F-8FB5C31E2ACC</gtr:id><gtr:title>Tourniquet-applied upper limb orthopaedic surgery results in increased inflammation and changes to leukocyte, coagulation and endothelial markers.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/743f709d7ab573ef65b67e4c848cf9c1"><gtr:id>743f709d7ab573ef65b67e4c848cf9c1</gtr:id><gtr:otherNames>Hughes SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>KHggwkmhzrz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7ABBBAC-6A9F-4ECC-9A9C-510C4D520394</gtr:id><gtr:title>Differential expression of syndecans and glypicans in chronically inflamed synovium.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a209ab3c760437e994ce730a3be2d59"><gtr:id>3a209ab3c760437e994ce730a3be2d59</gtr:id><gtr:otherNames>Patterson AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn><gtr:outcomeId>sUbwGMneAZh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AFA8199-1495-41BD-AAC7-619E9AA6E53E</gtr:id><gtr:title>Mild episodes of tourniquet-induced forearm ischaemia-reperfusion injury results in leukocyte activation and changes in inflammatory and coagulation markers.</gtr:title><gtr:parentPublicationTitle>Journal of inflammation (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/743f709d7ab573ef65b67e4c848cf9c1"><gtr:id>743f709d7ab573ef65b67e4c848cf9c1</gtr:id><gtr:otherNames>Hughes SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1476-9255</gtr:issn><gtr:outcomeId>aA4hjmuZRfD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EDE72D3-1235-40AC-9E95-344DD34E0770</gtr:id><gtr:title>Chemokines in inflammation: endothelial microvilli formation.</gtr:title><gtr:parentPublicationTitle>Inflammation Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52d4f14c44a0e058722facf9b15e990a"><gtr:id>52d4f14c44a0e058722facf9b15e990a</gtr:id><gtr:otherNames>Middleton, J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>CEA3B2EFD2C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A34D55DF-350F-4FF2-B51A-C2C8ED312723</gtr:id><gtr:title>Defining the fine structure of heparan sulfate on endothelial cells in rheumatoid synovium.</gtr:title><gtr:parentPublicationTitle>Annals of the Rheumatic Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64d7d53999bcd852c710b3091d573a0b"><gtr:id>64d7d53999bcd852c710b3091d573a0b</gtr:id><gtr:otherNames>Kehoe O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>43F817361CC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39DCC34F-2FFC-441D-AC70-278B33BCE9AD</gtr:id><gtr:title>Total hip and knee replacement surgery results in changes in leukocyte and endothelial markers.</gtr:title><gtr:parentPublicationTitle>Journal of inflammation (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/743f709d7ab573ef65b67e4c848cf9c1"><gtr:id>743f709d7ab573ef65b67e4c848cf9c1</gtr:id><gtr:otherNames>Hughes SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1476-9255</gtr:issn><gtr:outcomeId>oSvt1Jiw4kM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFD1B0D2-4047-4CDC-B36C-47143C81A514</gtr:id><gtr:title>Role of syndecan-3 in inflammation</gtr:title><gtr:parentPublicationTitle>Microcirculation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64d7d53999bcd852c710b3091d573a0b"><gtr:id>64d7d53999bcd852c710b3091d573a0b</gtr:id><gtr:otherNames>Kehoe O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>CJJCAcdNC2B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4CA3663-1313-4FBA-9B7C-5C005B17B5AC</gtr:id><gtr:title>Temporal expression pattern of Duffy antigen in rheumatoid arthritis: up-regulation in early disease.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f84c4830223926ea565f45b7ccb55842"><gtr:id>f84c4830223926ea565f45b7ccb55842</gtr:id><gtr:otherNames>Gardner L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>CB7LFvtVdJr</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401634</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>